Skip to main content

Spezifische Therapie sekundärer Hypertonieformen

  • Chapter
  • 125 Accesses

Zusammenfassung

Bei allen Formen der renoparenchymatösen Hypertonie (s. Kapitel 13.1) ist eine Blutdrucksenkung auf Werte < 130/80 mmHg anzustreben, um einerseits die Progression der Niereninsuffizienz zu verzögern und andererseits eine Schädigung weiterer Endorgane zu vermeiden. Ist die tägliche Eiweißausscheidung > 1 g, so ist der Blutdruck möglichst auf 125/75 mmHg zu senken. Die zeitliche Verzögerung der Niereninsuffizienz durch eine Senkung des Blutdruckes konnte sowohl bei der diabetischen Nephropathie (s. Kapitel 31.5.1) als auch bei nichtdiabetisch bedingten Nierenerkrankungen (IgA-Glomerulonephritis, hypertensive Nephropathie) eindrücklich belegt werden.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Al-Sobhi S, Peschel R, Bartsch G, Gasser R, Finkenstedt G, Janetschek G (2000) Partial laparoscopic adrenalectomy for aldosterone-producing adenoma: short-and long-term results. J Endourol 14:497–499

    Article  PubMed  CAS  Google Scholar 

  • Averbusch S, Streakley C, Young R, Gelmann E, Goldstein D, Stull R, Keiser H (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine and dacarbazine. Ann Intern Med 109:267–273

    Google Scholar 

  • Benoit G, Moukarzel M, Hiesse C, Verdelli G, Charpentier B, Fries D (1990) Transplant renal artery stenosis: experience and comparative results between surgery and angioplasty. Transplant Int 3:137–140

    CAS  Google Scholar 

  • Blum U, Krumme B, Flügel P, Gabelmann A, Lehnert T, Buitrago-Tellez C, Schollmeyer P, Langer M (1997) Treatment of ostial renal-artery stenosis with vascular endoprotheses after unsuccessful balloon angioplasty. N Engl J Med 336:459–465

    Article  PubMed  CAS  Google Scholar 

  • Bravo EL, Gifford RW (1984) Pheochromocytoma: diagnosis, localization, and management. N Engl J Med 311:1298–1303

    Article  PubMed  CAS  Google Scholar 

  • Deutsche Liga zur Bekämpfung des hohen Blutdruckes e.V. Deutsche Hypertonie Gesellschaft (1997) Renovaskuläre Hypertonie, Merkblatt, 2. Auflage. Heidelberg

    Google Scholar 

  • Ganguly A (1990) Glucocorticoid-suppressible hyperaldosteronism: an update. Am J Med 88:321–324

    Article  PubMed  CAS  Google Scholar 

  • Ghose RP, Hall PM, Bravo EL (1999) Medical management of aldosterone-producing adenomas. Ann Intern Med 131:105–108

    PubMed  CAS  Google Scholar 

  • Gifford RW, Manger WM, Bravo EL (1994) Pheochromocytoma. Endocrinol Metab Clin N Am 23:387–404

    Google Scholar 

  • Groth H, Vetter W, Stimpel M, Greminger P, Tenschert W, Klaiber E, Vetter H (1985) Adrenalectomy in primary aldosteronism: a long-term follow-up study. Cardiology 72(suppl l):107–116

    Article  PubMed  Google Scholar 

  • Guo J, Gong L, Chen S, Luo B, Xu M (1989) Malignant pheochromocytoma: diagnosis and treatment in fifteen cases. J Hypertens 7:261–266

    Article  PubMed  CAS  Google Scholar 

  • Harden PN, MacLeod MJ, Rodger RSC, Baxter GM, Connell JMC, Dominiczak AF, Junor BJR, Briggs JD, Moss JG (1997) Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 349:1133–1136

    Article  PubMed  CAS  Google Scholar 

  • Ibrahim HAA, Vora JP (1999) Hypertension in diabetes: a good opportunity to practise evidence-based medicine? A commentary on the UKPDS. J Hypertension 13:221–223

    CAS  Google Scholar 

  • Irvin GL, Carneiro DM (2000) Management changes in primary hyperparathyroidism. JAMA 284:936–938

    Article  Google Scholar 

  • Krempf M, Lumbroso J, Mornex R, Brendel AJ, Wemeau JL, Delisle MJ, Aubert B, Carpentier P, Fleury-Goyon MC, Gibold C, Guyot M, Lahneche B, Marchandise X, Schlumberger M, Charbonnel B, Chatal JF (1991) Use of m-131-iodobenzylguanidine in the treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 72:455–461

    Article  PubMed  CAS  Google Scholar 

  • Lafferty FW, Hubay CA (1989) Primary hyperparathyroidism. A review of the long-term surgical and nonsurgical morbidities as a basis for a rational approach to treatment. Arch Intern Med 149:789–796

    Article  PubMed  CAS  Google Scholar 

  • Manger WM, Gifford RW (1993) Pheochromocytoma: current diagnosis and management. Clev Clin J Med 60:365–378

    CAS  Google Scholar 

  • Marcantoni C, Jafar TH, Oldrizzi L, Levey AS, Maschio G (2000) The role of systemic hypertension in the progression of nondiabetic renal disease. Kidney Int 57(suppl 75): S44–S48

    Article  Google Scholar 

  • Olyaei AJ, de Mattos AM, Bennett WM (1999) A practical guide to the management of hypertension in renal transplant recipients. Drugs 58:1011–1027

    Article  PubMed  CAS  Google Scholar 

  • Orth DN (1995) Cushing’s syndrome. N Engl J Med 791–803

    Google Scholar 

  • Pelegri A, Romero R, Reguant M, Aisa L (1989) Non-resectable phaeochromocytoma: long-term follow-up. J Hum Hypertension 3:145–147

    CAS  Google Scholar 

  • Plouin PF, Chatelier G, Fofol I, Corvol P (1997) Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 29:1133–1139

    Article  PubMed  CAS  Google Scholar 

  • Plouin PF, Chatelier G, Darné B, Raynaud A for the Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group (1998) Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Hypertension 31:823–829

    Article  PubMed  CAS  Google Scholar 

  • Pommier RF, Brennan MF (1992) An 11-year experience with adrenocortical carcinoma. Surgery 112:963–971

    PubMed  CAS  Google Scholar 

  • Ramsay LE, Waller PC (1990) Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. Br Med J 300:569–572

    Article  CAS  Google Scholar 

  • Ritz E, Mann JFE (2000) Renal angioplasty for lowering blood pressure. N Engl J Med 342:1042–1043

    Article  PubMed  CAS  Google Scholar 

  • Rosenthal T (1993) Drug therapy of renovascular hypertension. Drugs 45:895–909

    Article  PubMed  CAS  Google Scholar 

  • Russo D, Andreucci VE, Iaccarino V, Niola R, Dal Canton A, Conte G (1988) Percutaneous renal embolisation in renovascular hypertension. Br Med J 296:1160–1161

    Article  CAS  Google Scholar 

  • Semple PF, Dominiczak AF (1994) Detection and treatment of renovascular disease: 40 years on. J Hypertens 12:729–734

    Article  PubMed  CAS  Google Scholar 

  • Shimon I, Melmed S (1998) Management of pituitary tumors. Ann Intern Med 129:472–483

    PubMed  CAS  Google Scholar 

  • Stimpel M, Wambach G (1987) Therapie des Phäochromozytoms. Dtsch med Wschr 112:1426–1427

    Article  PubMed  CAS  Google Scholar 

  • Stimpel M (1992) Therapie des primären Aldosteronismus. Dtsch med Wschr 117:947–949

    Article  PubMed  CAS  Google Scholar 

  • Swearingen B, Biller BMK, Barker FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT (1999) Long-term mortality after transsphenoidal surgery for Cushing’s disease. Ann Intern Med 130:821–824

    PubMed  CAS  Google Scholar 

  • Tanaka M, Tokuda N, Koga H, Kimoto Y, Naito S (2000) Laparoscopic adrenalectomy for pheochromocytoma: comparison with open adrenalectomy and comparison of laparoscopic surgery for pheochromocytoma versus other adrenal tumors. J Endourol 14:427–431

    Article  PubMed  CAS  Google Scholar 

  • Troncone L, Rufini V (1999) Nuclear medicine therapy of pheochromocytoma and paraganglioma. Q J Nucl Med 43:344–355

    PubMed  CAS  Google Scholar 

  • Tyagi S, Singh B, Kaul UA, Sethi KK, Arora R, Khalilullah (1993) Balloon angioplasty for renovascular hypertension in Takayasu’s arteritis. Am Heart J 125:1386–1393

    Article  PubMed  CAS  Google Scholar 

  • Van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FHM, Deinum J, Postma CT, Dees A, Woittiez AJJ, Bartelink AKM, Man in’t Veld A, Schalekamp MADH for the Dutch Renal Artery Stenosis Intervention Cooperative Study Group (2000) The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med 342:1007–1014

    Article  PubMed  Google Scholar 

  • Vetter W, Robertson JIS, Grim CE, Lüscher TF, Malborough J (1986) (eds) Renovascular hypertension. In memoriam Andreas Grüntzig. Cardiology 44(suppl 1):1–114

    Google Scholar 

  • Yamakita N, Chiou S, Gomez-Sanchez CE (1991) Inhibition of aldosterone biosynthesis by 18-ethynyl-deoxycorticosterone. Endocrinology 129:2361–2366

    Article  PubMed  CAS  Google Scholar 

  • Young WF Jr, Hogan MJ, Klee GG, Grant CS, van Heerden JA (1990) Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 65:96–110

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Stimpel, M. (2001). Spezifische Therapie sekundärer Hypertonieformen. In: Arterielle Hypertonie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57617-1_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57617-1_34

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63309-6

  • Online ISBN: 978-3-642-57617-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics